NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered peptides from WllyBIO? Mail in a sample (US only) and let us test it.

Test my supply
75%
Finnrick rating
#154 of 345 ranked vendors
29 of 38 classifiable tests passed
methodology · Purity focus
Finnrick analysis

WllyBIO's purity-focus record is strongest in GHK-Cu and later Retatrutide, where recent identity, purity, and fill results mostly clear the method. Tirzepatide is more volatile and BPC-157 is the weak spot, with repeated purity/fill misses; evidence is recent and moderately broad but consistently limited by missing batch IDs.

methodology →
vendor intelligence report
Vendor Intelligence Report: WllyBIO

Domain timing, Hong Kong registry searches, CMS fingerprints and a sister-domain storefront point away from WllyBIO’s public origin story. The report traces sales personas, payment rails and import exposure without treating the brand as a simple pass/fail call.

23 pages9 risk factors assessed3 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.06
90%
6
2
Retatrutide
$0.64
83%
15
3
Tirzepatide
$0.35
78%
12
4
BPC-157
-
44%
5
6
Tesamorelin
$1.86
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%3 Jul 2025: 58%3 Jul 2025: 46%16 Jul 2025: 60%21 Aug 2025: 63%31 Aug 2025: 65%31 Aug 2025: 65%31 Aug 2025: 65%31 Aug 2025: 64%31 Aug 2025: 64%31 Aug 2025: 64%31 Aug 2025: 65%31 Aug 2025: 65%31 Aug 2025: 64%10 Sept 2025: 64%18 Sept 2025: 63%18 Sept 2025: 65%30 Sept 2025: 65%17 Oct 2025: 66%17 Oct 2025: 67%29 Oct 2025: 67%29 Oct 2025: 69%30 Oct 2025: 69%4 Nov 2025: 69%17 Nov 2025: 70%17 Nov 2025: 70%29 Dec 2025: 71%29 Dec 2025: 71%29 Dec 2025: 71%28 Apr 2026: 72%28 Apr 2026: 72%28 Apr 2026: 72%6 Jun 2026: 73%6 Jun 2026: 73%15 Jun 2026: 74%5 Aug 2026: 74%5 Aug 2026: 73%25 Aug 2026: 73%5 Sept 2026: 73%28 Sept 2026: current 75%58%71%75%Jul 25Sep 26
Free peptide testing

Ordered peptides from WllyBIO? Mail in a sample (US only) and let us test it.

Test my supply
WllyBIO test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
5 Sep 2026
Pass
Tirzepatide
lab nameView COA
25 Aug 2026
Pass
Retatrutide
lab nameView COA
5 Aug 2026
Pass
GHK-Cu
lab nameView COA
5 Aug 2026
Fail
Retatrutide
lab nameView COA
15 Jun 2026
Pass
Retatrutide
lab nameView COA
6 Jun 2026
Pass
Retatrutide
lab nameView COA
6 Jun 2026
Pass
Retatrutide
lab nameView COA
28 Apr 2026
Pass
Tirzepatide
lab nameView COA
28 Apr 2026
Pass
Tirzepatide
lab nameView COA
28 Apr 2026
Pass
Tirzepatide
lab nameView COA
1-10 of 38

About WllyBIO test results from Finnrick

WllyBIO is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 4 peptides and 38 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible WllyBIO peptides in this dataset are BPC-157 (5 tests), GHK-Cu (6 tests) and Retatrutide (15 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 38 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered peptides from WllyBIO? Mail in a sample (US only) and let us test it.

Test my supply